{
  "trial_id": "NCT04236843",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Rome IV criteria for the diagnosis of IBS",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "investigated to exclude other gastrointestinal organic cause(s)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Moderate-to-severe IBS symptoms, as indicated by a score of \u2265175 on the IBS Severity Scoring System (IBS-SSS)",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnant or lactating women",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "The use of antibiotics or probiotics within 1 month prior to FMT",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Immunocompromised patients defined as those treated by immune-suppressive medications",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with co-morbidity such as kidney failure or chronic heart disease",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "System disease such as diabetes",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with serious psychiatric disorders or drug abuse",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a documented positive serum MPO-ANCA, indicating an autoimmune disease. He is being treated with corticosteroid and cyclophosphamides, which suggests immunosuppressive therapy.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT04236843",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}